BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Coagulation
,
Arthritis
,
Liver
,
Early pregnancy factor
,
Lipitor
,
rs3825942
,
PDX1
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
ovary
(tissue)
Summary
General Info
Body Atlas
Curated Studies
Most Correlated Studies
Ovarian cancer cells responses to overexpressing Rab25 and treatment with different growth factors
Ovarian cancer cell lines responses to norepinephrine
Cancer-associated fibroblasts in omentum
PAX2 knockdown in ovarian cancer cells
SKOV3 epithelial ovarian cancer cells with knockdown of EZH2
Explore Curated Studies Results
Literature
Most Relevant Literature
Polycystic ovary syndrome.
Update on the combination of myo-inositol/d-chiro-inositol for the treatment of polycystic ovary syn…
Emerging pollutants in etiology and pathophysiology of polycystic ovary syndrome.
Mitochondrial Dysfunction in Polycystic Ovary Syndrome.
Identification and validation of senescence-related genes in polycystic ovary syndrome.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Effect of Pneumoperitoneum on Human Ovary
Vitamin D Levels in Women With Polycystic Ovary Syndrome
Maturation of Follicles After Transplantation of Ovarian Tissue Into the Pelvic Wall and the Ovary
Serum Endocan Levels in Polycystic Ovary Syndrome
Diamel in the Treatment of Polycystic Ovary Syndrome
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ